Ligand validation:4EIL

CB3: 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID

CB3 is a Ligand Of Interest in 4EIL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4EIL_CB3_G_702	76%	11%	0.105	0.941	1.96	2.43	8	13	1	0	100%	1
4EIL_CB3_H_702	71%	16%	0.127	0.948	1.78	2.06	7	9	3	0	100%	1
4EIL_CB3_C_702	69%	17%	0.117	0.933	1.77	2	6	8	3	0	100%	1
4EIL_CB3_E_702	69%	15%	0.115	0.93	1.8	2.11	7	9	1	0	100%	1
4EIL_CB3_F_702	69%	16%	0.121	0.935	1.72	2.11	5	11	3	0	100%	1
4EIL_CB3_A_702	68%	12%	0.116	0.928	1.87	2.33	6	11	2	0	100%	1
4EIL_CB3_B_702	63%	16%	0.142	0.937	1.78	2.09	6	9	3	0	100%	1
4EIL_CB3_D_702	48%	16%	0.154	0.898	1.7	2.18	6	12	2	0	100%	1
6AOH_CB3_B_703	21%	19%	0.297	0.91	1.18	2.4	3	8	1	0	100%	0.5
6AOI_CB3_B_703	10%	20%	0.362	0.869	1.16	2.39	2	10	1	0	100%	0.5
5T0L_CB3_A_703	7%	21%	0.354	0.815	1.18	2.31	3	8	3	0	100%	0.5
6AOG_CB3_B_703	7%	21%	0.4	0.854	1.15	2.32	3	8	3	0	100%	0.5
6NNR_CB3_B_302	93%	21%	0.076	0.97	1.19	2.25	3	8	0	0	100%	1
4GEV_CB3_B_802	87%	21%	0.081	0.954	1.23	2.21	3	8	0	0	100%	1
2FTO_CB3_X_266	82%	19%	0.087	0.943	1.58	2	6	6	1	0	100%	1
6CDZ_CB3_A_701	53%	22%	0.16	0.922	1.31	2.06	3	11	0	0	100%	1
2OIP_CB3_B_608	43%	4%	0.208	0.934	3.17	2.93	25	18	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.